Video

Patient-to-Patient: What to Expect in a Clinical Trial

Janet Freeman-Daily, patient advocate and CURE contributor, discusses some key points that patients should know about enrolling in clinical trials.

Janet Freeman-Daily, patient advocate and CURE contributor, discusses some key points that patients should know about enrolling in clinical trials.

Freeman-Daily says that clinical trials are especially important for patients like her who have metastatic lung cancer, for which there is currently no cure but a number of options and clinical trials that may benefit patients.

Before joining a clinical trial, patients should know their risk and understand the difference between each of the three phases of clinical trials. Also, patients should never think that they may not be treated in a clinical trial. Even if randomized to placebo, they will always get the best standard of care.

Related Videos
Dr. Michael Bogenschutz
Photo credit: Max Mumby/Indigo via Getty Images
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Stephanie Alice Baker
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
Dr. Richard “Rick" Winneker